{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie gravidique précoce : Questions médicales les plus fréquentes",
"headline": "Maladie gravidique précoce : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie gravidique précoce : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vomissement",
"url": "https://questionsmedicales.fr/mesh/D014839",
"about": {
"@type": "MedicalCondition",
"name": "Vomissement",
"code": {
"@type": "MedicalCode",
"code": "D014839",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hyperémèse gravidique",
"alternateName": "Hyperemesis Gravidarum",
"url": "https://questionsmedicales.fr/mesh/D006939",
"about": {
"@type": "MedicalCondition",
"name": "Hyperémèse gravidique",
"code": {
"@type": "MedicalCode",
"code": "D006939",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937.049.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce",
"alternateName": "Morning Sickness",
"code": {
"@type": "MedicalCode",
"code": "D048968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dae Yul Kim",
"url": "https://questionsmedicales.fr/author/Dae%20Yul%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Min Ho Chun",
"url": "https://questionsmedicales.fr/author/Min%20Ho%20Chun",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "JaYoung Kim",
"url": "https://questionsmedicales.fr/author/JaYoung%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "T Requena",
"url": "https://questionsmedicales.fr/author/T%20Requena",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biotecnología y Microbiología de Alimentos, Instituto de Investigación en Ciencias de la Alimentación (CIAL-CSIC), Madrid, España. Electronic address: t.requena@csic.es."
}
},
{
"@type": "Person",
"name": "M Velasco",
"url": "https://questionsmedicales.fr/author/M%20Velasco",
"affiliation": {
"@type": "Organization",
"name": "Sección de Enfermedades Infecciosas, Medicina Interna, Hospital Universitario Fundación Alcorcón, Alcorcón, España."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complexities of Prostate Cancer.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36430730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232214257"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes digestifs",
"item": "https://questionsmedicales.fr/mesh/D012817"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vomissement",
"item": "https://questionsmedicales.fr/mesh/D014839"
},
{
"@type": "ListItem",
"position": 6,
"name": "Maladie gravidique précoce",
"item": "https://questionsmedicales.fr/mesh/D048968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie gravidique précoce - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie gravidique précoce",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie gravidique précoce",
"description": "Comment diagnostiquer la maladie gravidique précoce ?\nQuels examens sont nécessaires pour le diagnostic ?\nQuand consulter un médecin pour des nausées ?\nLes nausées matinales sont-elles normales ?\nPeut-on confondre avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie gravidique précoce",
"description": "Quels sont les symptômes typiques ?\nLes symptômes varient-ils d'une femme à l'autre ?\nLes nausées surviennent-elles à tout moment ?\nY a-t-il des symptômes associés ?\nLes vomissements sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie gravidique précoce",
"description": "Peut-on prévenir les nausées matinales ?\nQuels aliments éviter pour réduire les symptômes ?\nLe stress influence-t-il les nausées ?\nL'hydratation aide-t-elle à prévenir les nausées ?\nLes vitamines peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie gravidique précoce",
"description": "Quels traitements sont disponibles ?\nLes remèdes naturels sont-ils efficaces ?\nQuand utiliser des médicaments ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils sûrs pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie gravidique précoce",
"description": "Quelles complications peuvent survenir ?\nComment reconnaître une complication ?\nLes complications affectent-elles le bébé ?\nQuelles sont les conséquences d'une déshydratation ?\nL'hyperémèse gravidique est-elle fréquente ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie gravidique précoce",
"description": "Quels sont les facteurs de risque connus ?\nL'âge de la mère influence-t-il les nausées ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes fumeuses sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la maladie gravidique précoce ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes rapportés par la patiente et l'exclusion d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun examen spécifique n'est requis, mais des analyses sanguines peuvent être faites si nécessaire."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des nausées ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter si les nausées sont sévères ou persistent au-delà du premier trimestre."
}
},
{
"@type": "Question",
"name": "Les nausées matinales sont-elles normales ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont fréquentes et généralement considérées comme normales durant la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est important d'exclure d'autres causes comme des infections ou des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, vomissements, fatigue et hypersensibilité aux odeurs."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une femme à l'autre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les femmes."
}
},
{
"@type": "Question",
"name": "Les nausées surviennent-elles à tout moment ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que souvent matinales, les nausées peuvent survenir à tout moment de la journée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête ou des changements d'humeur peuvent également apparaître."
}
},
{
"@type": "Question",
"name": "Les vomissements sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vomissements peuvent survenir chez certaines femmes, mais ne sont pas systématiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les nausées matinales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais des changements alimentaires peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour réduire les symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments gras, épicés et les odeurs fortes qui peuvent aggraver les nausées."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les nausées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes, il est donc conseillé de pratiquer des techniques de relaxation."
}
},
{
"@type": "Question",
"name": "L'hydratation aide-t-elle à prévenir les nausées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, rester bien hydraté peut aider à réduire l'intensité des nausées."
}
},
{
"@type": "Question",
"name": "Les vitamines peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vitamines, comme la vitamine B6, peuvent aider à réduire les symptômes chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des changements alimentaires, des médicaments anti-nauséeux et l'hydratation."
}
},
{
"@type": "Question",
"name": "Les remèdes naturels sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des remèdes comme le gingembre ou les tisanes peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand utiliser des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments sont recommandés si les symptômes sont sévères et affectent la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent avoir des effets secondaires, il est donc important de consulter."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils sûrs pendant la grossesse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des traitements sont considérés comme sûrs, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la déshydratation ou l'hyperémèse gravidique peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des vomissements fréquents, une perte de poids ou des douleurs abdominales nécessitent une consultation."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le bébé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, des complications peuvent affecter la santé du bébé, d'où l'importance d'un suivi médical."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une déshydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des complications graves, y compris des problèmes rénaux et des déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "L'hyperémèse gravidique est-elle fréquente ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'hyperémèse gravidique est rare mais nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de nausées dans des grossesses précédentes et des grossesses multiples."
}
},
{
"@type": "Question",
"name": "L'âge de la mère influence-t-il les nausées ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus jeunes, notamment celles de moins de 20 ans, peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de nausées matinales peut augmenter le risque chez la mère."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel et physique peut augmenter la probabilité de développer des nausées."
}
},
{
"@type": "Question",
"name": "Les femmes fumeuses sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut influencer l'intensité des nausées matinales chez certaines femmes."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...
To report outcomes within the Rapid Assessment for Prostate Imaging and Diagnosis (RAPID) diagnostic pathway, introduced to reduce patient and healthcare burdens and standardize delivery of pre-biopsy...
A total of 2130 patients from three centres who completed the RAPID pathway (3 April 2017 to 31 March 2020) were consecutively entered as a prospective registry. These patients were also compared to a...
The median patient age and PSA level were 66 years and 6.6 ng/mL, respectively. Biopsy could be omitted in 43% of patients (920/2130). A further 7.9% of patients (168/2130) declined a recommendation f...
The RAPID prostate cancer diagnostic pathway allows 43% of men to avoid a biopsy while preserving good detection of clinically significant cancers and low detection of insignificant cancers, although ...